loadpatents
Patent applications and USPTO patent grants for Laliberte; Sebastien.The latest application filed is for "renin inhibitors".
Patent | Date |
---|---|
3,4-substituted piperidine derivatives as renin inhibitors Grant 8,889,714 - Chen , et al. November 18, 2 | 2014-11-18 |
Case of renin inhibitors Grant 8,343,968 - Wu , et al. January 1, 2 | 2013-01-01 |
Renin Inhibitors App 20120190701 - Chen; Austin Chih-Yu ;   et al. | 2012-07-26 |
Renin Inhibitors App 20120035214 - McKay; Daniel J. ;   et al. | 2012-02-09 |
Renin inhibitors Grant 8,076,359 - Dube , et al. December 13, 2 | 2011-12-13 |
Renin Inhibitors App 20110237622 - Chen; Austin Chih-Yu ;   et al. | 2011-09-29 |
3,4-substituted Piperidine Derivatives As Renin Inhibitors App 20110152316 - Chen; Austin Chih-Yu ;   et al. | 2011-06-23 |
Pharmaceutical phenylquinoline and chromen-2-one triazole compounds Grant 7,960,409 - Grimm , et al. June 14, 2 | 2011-06-14 |
3,4-substituted Piperidine Derivatives As Renin Inhibitors App 20110053940 - Chen; Austin Chih-Yu ;   et al. | 2011-03-03 |
Novel Case Of Renin Inhibitors App 20100120859 - Wu; Tom Yao-Hsiang ;   et al. | 2010-05-13 |
Renin Inhibitors App 20100063091 - Dube; Daniel ;   et al. | 2010-03-11 |
Novel Pharmaceutical Compounds App 20090227638 - Blouin; Marc ;   et al. | 2009-09-10 |
Pharmaceutical compounds Grant 7,553,973 - Blouin , et al. June 30, 2 | 2009-06-30 |
Novel pharmaceutical compounds App 20090030048 - Blouin; Marc ;   et al. | 2009-01-29 |
7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors Grant 7,439,260 - Gareau , et al. October 21, 2 | 2008-10-21 |
Novel pharmaceutical compounds App 20080188521 - Grimm; Erich L. ;   et al. | 2008-08-07 |
Novel pharmaceutical compounds App 20070149579 - Blouin; Marc ;   et al. | 2007-06-28 |
7-(1,3-thiazol-2-yl)thio!-coumarin derivatives and their use as leukotriene biosynthesis inhibitors App 20060116406 - Gareau; Yves ;   et al. | 2006-06-01 |
Use of phosphodiesterase-4 inhibitors as enhancers of cognition App 20060040981 - Dube; Daniel ;   et al. | 2006-02-23 |
Alkyne-aryl phosphodiesterase-4 inhibitors App 20050070569 - Guay, Daniel ;   et al. | 2005-03-31 |
Tri-aryl-substituted-ethane PDE4 inhibitors Grant 6,841,564 - Freisen , et al. January 11, 2 | 2005-01-11 |
Alkyne-aryl phosphodiesterase-4 inhibitors Grant 6,743,802 - Guay , et al. June 1, 2 | 2004-06-01 |
1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors Grant 6,677,351 - Li , et al. January 13, 2 | 2004-01-13 |
Alkyne-aryl phosphodiesterase-4 inhibitors App 20030114478 - Guay, Daniel ;   et al. | 2003-06-19 |
1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors App 20030096829 - Li, Chun ;   et al. | 2003-05-22 |
Tri-aryl-substituted-ethane PDE4 inhibitors App 20020173661 - Freisen, Richard ;   et al. | 2002-11-21 |
Tri-aryl-substituted-ethane PDE4 inhibitors App 20020013347 - Freisen, Richard ;   et al. | 2002-01-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.